90 results
424B5
BSGM
Biosig Technologies Inc
30 May 24
Prospectus supplement for primary offering
11:25am
, and prospective investors. The Engagement Agreement does not give rise to any commitment by the Placement Agent to purchase any of the securities … that it will be able to raise new capital in any prospective offering. The Placement Agent has no commitment to buy any of the securities offered
8-K
EX-99.1
BSGM
Biosig Technologies Inc
3 May 24
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately
8:30am
to thank our many loyal shareholders and reiterate my unwavering commitment to both restore and create shareholder value.”
The Company will continue
8-K
EX-99.1
h3dxm plp1dnu6w7
6 Dec 23
Regulation FD Disclosure
5:07pm
424B5
sj8utb6kl1w j4aqz5
13 Nov 23
Prospectus supplement for primary offering
8:30am
8-K
EX-99.1
eb86zvc6fw4fhp 6i0z
2 Nov 23
Regulation FD Disclosure
8:00am
8-K
EX-99.1
qgeez2lrt4 gd6bs06do
23 Aug 23
BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, Customizations
8:30am
8-K
EX-99.1
dpsp5n sf26vl2s
22 Aug 23
Latest Software Release Supports Electrophysiologists with Visualizing Heart Patterns Difficult to Recognize with the Naked Eye
8:00am
8-K
EX-10.1
6aeloy
21 Jul 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
fu862iapn0zh lj6jl
30 Jun 23
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-99.1
w2iowgnbht8wm
28 Apr 23
Regulation FD Disclosure
5:11pm
8-K
EX-99.1
momr9eoszwn402o3dckx
24 Oct 22
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology
4:48pm